BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen NT, Pacelli A, Nader M, Kossatz S. DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy. Cancers (Basel) 2022;14:1129. [PMID: 35267438 DOI: 10.3390/cancers14051129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Destro G, Chen Z, Chan CY, Fraser C, Dias G, Mosley M, Guibbal F, Gouverneur V, Cornelissen B. A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy. Nucl Med Biol 2023;116-117:108312. [PMID: 36621256 DOI: 10.1016/j.nucmedbio.2022.108312] [Reference Citation Analysis]
2 Wang Q, Zhang J. Current status and progress in using radiolabelled PARP-1 inhibitors for imaging PARP-1 expression in tumours. Eur J Med Chem 2022;242:114690. [PMID: 36041258 DOI: 10.1016/j.ejmech.2022.114690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pacelli A, Zarrad F, Fendler WP, Herrmann K, Nader M. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. Pharmaceuticals 2022;15:865. [DOI: 10.3390/ph15070865] [Reference Citation Analysis]